Artiva Biotherapeutics, Inc. ARTV Cash Flow Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| -$83.87M-28.3% | -$65.37M-128% | ||
| $2.6M+6.8% | $2.43M— | ||
| $6.82M-2.3% | $6.98M— | ||
| -$76.75M-39.5% | -$55.03M— | ||
| $2.59M+303% | $642K— | ||
| $63.41M+153% | -$120.46M— | ||
| —— | —— | ||
| -$14.52M-9.5% | -$13.27M— | ||
| -$79.34M-42.5% | -$55.67M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Artiva Biotherapeutics, Inc. generate?
- Artiva Biotherapeutics, Inc. (ARTV) generated -$77.9M in operating cash flow over the trailing twelve months.
- What is Artiva Biotherapeutics, Inc.'s free cash flow?
- After $2.3M of capital expenditures, Artiva Biotherapeutics, Inc.'s free cash flow was -$80.2M over the trailing twelve months, down 31.6% year over year.
- Where does Artiva Biotherapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Artiva Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.